Phase 2 study of A797, an oral, selective p38 mitogen-activated protein kinase inhibitor, in patients with lamin A/C-related dilated cardiomyopathy MacRae, C., Taylor, M. G., Mestroni, L., Moses, J. R., Ashley, E. A., Wheeler, M. T., Lakdawala, N. K., Hershberger, R. E., Ptaszynski, M., Sandor, V., Saunders, M. E., Oliver, C., Lee, P. A., Judge, D. P. OXFORD UNIV PRESS. 2016: 1011

View details for Web of Science ID 000383869505075